Lomefloxacin - Novartis Ophthalmics

Drug Profile

Lomefloxacin - Novartis Ophthalmics

Alternative Names: Okacyn

Latest Information Update: 03 Apr 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Abbott Japan
  • Developer Novartis Ophthalmics
  • Class Antibacterials; Fluoroquinolones; Small molecules
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Infectious conjunctivitis

Most Recent Events

  • 28 Feb 2003 Dainabot has merged with Hokuriku Seiyaku to form Abbott Japan
  • 03 Apr 2001 Launched for Conjunctivitis in Spain (Ophthalmic)
  • 25 Aug 2000 Registered for Conjunctivitis in Spain (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top